---
title: "Pulse Biosciences, Inc. (PLSE.US) — 公司概况"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/PLSE.US/overview.md"
symbol: "PLSE.US"
name: "Pulse Biosciences, Inc."
parent: "https://longbridge.com/zh-CN/quote/PLSE.US.md"
datetime: "2026-04-15T23:15:00.888Z"
locales:
  - [en](https://longbridge.com/en/quote/PLSE.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PLSE.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PLSE.US/overview.md)
---

# Pulse Biosciences, Inc. (PLSE.US) — 公司概况

## 基本信息

| 项目 | 详情 |
|------|--------|
| 行业 | 医疗器械 |
| 交易所 | US Market |
| 地址 | 601 Brickell Key Drive, Suite 1080, Miami, Florida, United States |
| 官网 | [www.pulsebiosciences.com](https://www.pulsebiosciences.com) |

## 公司简介

Pulse Biosciences, Inc. 是一家新型生物电医学公司。它提供 nPulse 系统，这是一种新颖的纳秒脉冲场消融输送平台，用于治疗皮肤良性病变；nPulse Vybrance 经皮电极系统，用于外科环境中的软组织消融；nPulse 心脏外科夹，旨在用于心房颤动（AF）的外科治疗；nPulse 心脏导管系统，旨在提供一次治疗周期内的环形消融；以及 nPulse 控制台，这是一种基于软件的控制台平台，旨在适应医生所偏好的临床工作流程。该公司之前被称为 Electroblate, Inc

## 核心管理层

| 名称 | 职位 |
|------|-------|
| Paul Arthur LaViolette | President, CEO & Co-Chairman of the Board |
| Robert W. Duggan | Independent Co-Chairman |
| Darrin R. Uecker | CTO & Director |
| Jon Skinner | Chief Financial Officer |
| Liane Teplitsky | Chief Operating Officer |
| Steven T. Weber | VP of Accounting, Principal Accounting Officer & Global Corporate Controller |
| Manmeet Singh Soni | Lead Independent Director |
| Mahkam Zanganeh | Independent Director |

## 主要股东

| 名称 | 占比 | 报告日期 |
|------|-------|-------------|
| Robert W. Duggan | 70.83% | 2025-10-22 |
| BlackRock, Inc. | 2.00% | 2025-12-31 |
| The Vanguard Group, Inc. | 1.65% | 2025-12-31 |
| Mahkam Zanganeh | 1.28% | 2025-10-22 |
| Bank of America Corporation | 1.18% | 2025-12-31 |
| Genius Inc. | 0.93% | 2025-10-22 |
| Geode Capital Management, LLC | 0.68% | 2025-12-31 |
| State Street Global Advisors, Inc. | 0.66% | 2025-12-31 |
| Portolan Capital Management, LLC | 0.58% | 2025-12-31 |
| Darrin R. Uecker | 0.42% | 2025-10-22 |

## 业务构成

| 业务线 | 营收 | 占比 |
|---------|---------|-------|
| 外科和医疗设备 | 350000 | 100% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Pulse Biosciences, Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "外科和医疗设备",
        "ratio": 100
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```


---

> **免责声明: 本文仅供参考，不构成任何投资建议。**